BridgeBio Pharma | SCHEDULE 13G/A: Others
BridgeBio Pharma | SCHEDULE 13D/A: Others
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner VIKING GLOBAL INVESTORS LP
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director MCCORMICK FRANK
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Satvat Ali J.
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director MCCORMICK FRANK
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas